Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient

被引：6
|
作者：
Niscola, Pasquale [1 ,5 ]
Mazzone, Carla [1 ]
Fratoni, Stefano [2 ]
Ardu, Nicolina Rita [1 ]
Cesini, Laura [1 ]
Giovannini, Marco [1 ]
Ottone, Tiziana [4 ]
Anemona, Lucia [3 ]
Voso, Maria Teresa [4 ]
de Fabritiis, Paolo [1 ]
机构：
[1] ASL Roma 2, S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] ASL Roma 2, S Eugenio Hosp, Pathol Dept, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[5] S Eugenio Hosp, Hematol Unit, Piazzale Umanesimo 10, I-00144 Rome, Italy
来源：
ACTA HAEMATOLOGICA | 2023年 / 146卷 / 05期
关键词：
Acute myeloid leukemia; Leukemia cutis; Nucleophosmin-1; Venetoclax; azacitidine; VENETOCLAX;
D O I：
10.1159/000531101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe a case of acute myeloid leukemia with NPM1 mutation and disseminated leukemia cutis in a very old patient, who achieved a long-lasting response to the azacitidine/venetoclax combination with molecular complete remission, given the potential value of this rarely observed clinical outcome.
引用
收藏
页码：408 / 412
页数：5
相关论文
共 50 条
  • [41] Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission
    Gorin, Norbert-Claude
    Labopin, Myriam
    Meloni, Giovanna
    Pigneux, Arnaud
    Esteve, Jordi
    Mohty, Mohamad
    HAEMATOLOGICA, 2013, 98 (02) : E12 - E14
  • [42] Synergistic Effects of the RARalpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
    Fleischmann, Maximilian
    Bechwar, Julia
    Voigtlaender, Diana
    Fischer, Mike
    Schnetzke, Ulf
    Hochhaus, Andreas
    Scholl, Sebastian
    CANCERS, 2024, 16 (07)
  • [43] Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status
    Reis, Rogerio
    Muller, Gabriel S.
    Santos, Mariane M.
    Santos, Allan S.
    Santos, Herbert
    Santos, Lorene S.
    Lopes, Bruno A.
    Trindade, Soraya C.
    Meyer, Roberto J.
    Freire, Songeli M.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2025, 34 (02) : 115 - 123
  • [44] Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment
    Lachowiez, Curtis A.
    Reville, Patrick K.
    Kantarjian, Hagop
    Jabbour, Elias
    Borthakur, Gautam
    Daver, Naval
    Issa, Ghayas
    Furudate, Ken
    Tanaka, Tomoyuki
    Pierce, Sherry
    Tang, Guilin
    Patel, Keyur P.
    Medeiros, Jeffrey
    Abbas, Hussein A.
    Haddad, Fadi
    Hammond, Daniel
    Short, Nicholas J.
    Maiti, Abhishek
    Yilmaz, Musa
    Sasaki, Koji
    Takahashi, Koichi
    Pemmaraju, Naveen
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    Loghavi, Sanam
    DiNardo, Courtney D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : 1443 - 1452
  • [45] IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Mitsuya, Hiroaki
    Asou, Norio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 471 - 477
  • [46] Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome
    Masaharu Akiyama
    Masayoshi Yamaoka
    Yoko Mikami-Terao
    Wataru Ohyama
    Kentaro Yokoi
    Yasuhiro Arakawa
    Junko Takita
    Hideaki Suzuki
    Hisashi Yamada
    International Journal of Hematology, 2015, 102 : 723 - 728
  • [47] Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient population
    Suzuki, Rikio
    Onizuka, Makoto
    Kojima, Minoru
    Shimada, Masako
    Okamura, Kaori
    Fukagawa, Satomi
    Tsuboi, Kosuke
    Kikuchi, Ako
    Kobayashi, Hiroyuki
    Shintani, Ayumi
    Ogawa, Yoshiaki
    Kawada, Hiroshi
    Hotta, Tomomitsu
    Ando, Kiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (05) : 422 - 428
  • [48] Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
    Xavier Thomas
    Oncology and Therapy, 2024, 12 : 57 - 72
  • [49] Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome
    Akiyama, Masaharu
    Yamaoka, Masayoshi
    Mikami-Terao, Yoko
    Ohyama, Wataru
    Yokoi, Kentaro
    Arakawa, Yasuhiro
    Takita, Junko
    Suzuki, Hideaki
    Yamada, Hisashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 723 - 728
  • [50] Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
    Thomas, Xavier
    ONCOLOGY AND THERAPY, 2024, 12 (01) : 57 - 72
12345